Drug Trial Radar · NCT02390050
A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Jun 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
292
Actual
Start
May 12, 2015
Primary completion
Jun 3, 2016
Study completion Jun 3, 2016
Sponsor
- Lead sponsor
- TheracosIndustry
- Sponsor type
- Industry
- First posted
- Mar 17, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM). Bexagliflozin is an orally administered drug for the treatment of T2DM and is classified as a Sodium Glucose co-Transporter 2 (SGLT2) Inhibitor. This study was to enroll both treatment naive and those subjects previously treated with one oral hypoglycemic agent (OHA). Approximately 320 subjects eligible for randomization was to receive bexagliflozin tablets, 5, 10, 20 mg or placebo, once daily for 12 weeks in an outpatient setting.
Conditions
- Diabetes Mellitus, Type 2
Interventions
Bexagliflozin tabletsDrug
Bexagliflozin tablets are blue caplet-shaped, film-coated tablets that are intended for use in investigational studies in humans.
Bexagliflozin tablets, placeboDrug
Bexagliflozin tablets, placebo, are blue caplet-shaped, film-coated tablets that are intended for use in investigational studies in humans.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in HbA1c After 12 Weeks of TreatmentTime frame: 12 weeks
Locations
50 sites in 2 countries. Site status is shown where the registry gives one.
Phoenix Medical Research Institute LLC
Peoria, Arizona
Advanced Arizona Clinical Research
Tucson, Arizona
Hope Clinical Research, LLC
Canoga Park, California
Catalina Research Institute
Chino, California
National Research Institute
Huntington Park, California
Long Beach Clinical Trials
Long Beach, California
Synergy San Diego
National City, California
Northern California Research
Sacramento, California
Artemis Institute for Clinical Research, LLC
San Diego, California
Infosphere Clinical Research, Inc
West Hills, California
M&O Clinical Research LLC
Fort Lauderdale, Florida
AGA Clinical Trials
Hialeah, Florida
Compass Research North
Leesburg, Florida
Sweet Hope Research Specialty, Inc
Miami Lakes, Florida
Sunshine Research Center
Opa-locka, Florida
Compass Research LLC
Orlando, Florida
Progressive Medical Research
Port Orange, Florida
PICR Clinic
Atlanta, Georgia
Sundance Clinical Research
St Louis, Missouri
Premier Research Ltd
Trenton, New Jersey
Regional Clinical Research, Inc
Endwell, New York
Calabash Medical Center
Calabash, North Carolina
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina
PMG Research of Salisbury
Salisbury, North Carolina
CTI Research
Cincinnati, Ohio
Summit Research Group, LLC
Stow, Ohio
Columbia Research Group, Inc.
Portland, Oregon
Detweiler Family Medicine and Associate, P.C.
Lansdale, Pennsylvania
North Myrtle Beach Family Practice
Myrtle Beach, South Carolina
Global Medical Research
DeSoto, Texas
Rockwood Medical Clinic
Fort Worth, Texas
Wasatch Clinical Research
Salt Lake City, Utah
Medical Corporation Hitomi-kai Motomachi Takatsuka Naika Clinic
Yokohama Naka-ku, Kanagawa, Japan
Medical Corporation Hayashi katagihara Clinic
Nishikyo-ku, Kyoto, Japan
Medical Corporation KEISEIKAI Kajiyama clinic
Ukyou-ku, Kyoto, Japan
Ikeoka Medical Corp. Ikeoka Clinic
Joto-ku, Osaka, Japan
Miyauchi Medical Center
Takatsuki-shi, Osaka, Japan
Medical Corporation Senrichuo Ekimae Clinic
Toyonaka-shi, Osaka, Japan
Medical Corporation Segawa Hospital
Hikigun Ogawamachi, Saitama, Japan
Medical Corporation Yukeikai Asano Clinic
Kawagoe-shi, Saitama, Japan
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.